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nT difkrcnt axygetwierivcd rpccicx in DNA elr:~vagc rcnctionx, w LIIJCS rhc extcnf uf oxidalivc dnmrgc to DNA in viva and tc) invcsliptitc lhcr 
mcch:mixm of DNA dww\gc by iuoixing redi&n nnd rhcnrieal careinugcnx. 
I. INTRODUCTION 
It is well-esrablished rhar aerobic organisms conxrant- 
ly produce small amounrs of reactive oxygen species’, 
including supcroxidc radical (OF), hydrogen peroxide 
(HZ@) and hypochlorous acid (HOCl), the latter being 
generated by the enzyme mycloperoxidase in 
ncutrophils [l-3]. Exposure of living organisms to 
background levels of ionizing radiation leads to 
homolytic fission of oxygen-hydrogen bonds in water 
to produce hydroxyl radical, ‘OH [4], Hydroxyl radical 
can also be generated when Hz02 comes into contact 
with certain transition metal ion chelates, especially 
those of iron and copper [S], In general, the reduced 
forms ,of these metal ions (Fe2’“, Cu”) produce ‘OH at 
a faster rate upon reaction with Hz02 than the oxidized 
forms (Fe’+) Cu2’) and so reducing agents such as 01 
and ascorbic acid can often accelerate ‘OH generation 
by metal ion/H2Oz mixtures [S]. However, both Cu2* 
[6,7j and certain Fe3”-complexes (especially 
Fe3*-nitrilotriacetic acid) do generate some ‘OH upon 
raction with Hz02 [$-IO], In the case of ferric-NTA 
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’ ‘Reucrive o_~_~gen species’ is 2 collective term used in the biomedical 
literature that includes oxygencontaining radicals (such as Of, 
‘OK, RO’, R02’) and non-radical species that can produce oxygcn- 
containing radicals during their reactions (HzOz, 03, singlet OrlAg, 
HOCI). The term ‘reactive’ isrelative; for example, Oi is very much 
less chemically reactive than is ‘OH. 
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complexes, Or is somehow involved in the ‘OH Forma- 
tion in rhc presence of HZ&, since it is almost complete- 
ly inhibited by the O:-scavenging enzyme superoxidc 
dismucase [9,10]. 
Aerobes have evolved antioxidant defences to protect 
thcmsclvcs against the reactive oxygen species’ 
generated in viva, These clefences include enzymes 
(such as supcroxide dismutasc, catalast: and glutathionr 
pcroxidasc), low molecular mass agents (examples be- 
ing cr-tocopherol and ascorbic acid) and proteins that 
bind metal ions in forms unable to accelerate free 
radical reactions [ 1,2,1 l-l 31. Oxidative sfress results 
when reactive oxygen species are not adequately remov- 
ed. This can happen if antioxidants are depleted and/or 
if the formation of reactive oxygen species is increased 
beyond the ability of the defences to cope with them [2]. 
Subjecting cells to oxidative stress can result in severe 
metabolic dysfunctions, including peroxidation of 
membrane lipids, depletion of nicotinamide nucleo- 
tides, rises in intracellular free Ca** ions, cytoskeletal 
disruption and DNA damage, The latter is often 
measured as formation of single-strand breaks; double 
strand breaks or chromosomal aberrations. Methods 
for measuring DNA strand breaks have recently been 
discussed [14-161. Indeed, DNA damage has been 
almost invariably observed in a wide range of mamma- 
lian cell types exposed to oxidative stress [16-441. The 
systems used to impose oxidative stress upon cells have 
included exposure to elevated oxygen concentrations 
[42], incubation with enzymes that generate reactive ox- 
ygen species (such as xanthine oxidase plus its 
substrates, xanthine or hypoxanthine [18,22-27]), 
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rllircct ;additien to the exllxp al H$~z [i8,2&=32,43,44, 
44e,bf, sPsrgsrnichydr~peroxidem [3%36,44~1lr,45], or of 
ceinpound~ whaae metakmlism by the? cell ~eswltr in in= 
creased, inrraeeliuirr g~r~~r~ti~n ST Oi and H$& (such. 
ms paraquat end mcnndieane (LOJI:]}, and c&ncubation 
of the eclls with de-tivrtcd phagacytes such PJ 
mncrephr#cs [38) and neutrophiis [18,39-411, Ar. 
civnted ncutrophils and tntlcrophages generate 0: and 
HrOp: in addition, +utrephiis produce HOC1 [Zjr46), 
Neutrophils do not produce *OH unleaa a s~urcc OF 
rransition metal ions is added to the incubation mlx- 
cure, ix. neutraphils do not them&es appear to can. 
tain nny form of metnl ion cntalyse that will convert 
HaOr into ‘OH [47-49)‘. Oxidative stress [XJ-541 and 
DNA dnmagc [51 J also occur when some mammzGtln 
cclis are exposed to tumor necrosis factor. The DNA 
damngt: produced in human cetis by exposure to 
cigarette smoke [55,55a,56], asbestos [57,58), ozone 
(60,61 J or to ecrtain carcinogenic met&, such as nickel 
(591, haa also been suggested to involve reactive oxygen 
specks, 
2. POSSIBLE MECHANISMS OF DNA DAMAGE 
INDUCED BY OXIDATIVE STRESS 
Why does oxidative st ress cause DNA damage? In the 
case of extcrnaiiy-generated reaccivc oxygen species 
(e.g. when cells arc incubated with HzOZ, activated 
phagocytes or xanthine oxidase plus its substrates) 
damage is usually inhibited, by adding cataiase, showing 
that Hz02 is needed. Superoxide dismutase (SOD) does 
not usually inhibit much, which could mean either that 
Or’ is not involved in the DNA damage, or that SOD 
does not enter cells easily. That the tatter interpretation 
is correct in at least one cell system is shown by the 
observations that SOD can protect hepatocytes from 
the toxicity of Hz02 or f-butylhydroperoxide under 
conditions where it does enter the cells [62,63], 
However, neither 0; nor Hz02 undergoes any chemical 
reaction with DNA, as measured by strand breakage 
[64-661 or by chemical changes in the deoxyribose, 
purines or pyrimidines [9,67,68]. Hence, DNA damage 
by oxidative stress cannot involve direct attack of 01 or 
of H202 upon the DNA. 
Two explanations of the DNA damage have been ad- 
vanced (Fig. 1). First, it is possible that the damage is 
due to ‘OH radical formation [30]. Thus, it is envisaged 
that M202, which crosses biological membranes easily 
[69J, can penetrate to the nucleus and react with ions of 
iron or copper to form ‘OH. Because of the high reac- 
tivity of ‘OH and its resultant inability to diffuse 
significant distances within the ceil [69], this mechanism 
is only feasible if the, ‘OH is generated from Hz01 by 
reaction with metal ions bound upon or very close to the 
DNA. One possibility is that these metal ions might 
always be present bound to the DNA in vivo. For exam- 
pie, copper ions are thought to be present in 
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~hr~m~%~rn~~ I781tend copper iona &re very cffeetivo in 
promoting H~~~-d~p~n~l~nt dramage to iaolnted DNA 
t&7) ana 5~ DNA within chramtstin [71J in vitrs, A x1?- 
erand ~~$~ibility ir thert ths mcttttl iana might be releasrd 
within the crll w U nrutt of oxidntive mess, mt then 
bind to the DNA /71]. Thus, just ns oxidntive stress 
EBWILC?L rises in intr~ellula~ free, Clrrc, it rntxy cause rises 
in intraccllulrr Prcc Iron and&r copper ions that could 
bind to DNA and make it w target far oxidative dtrmnp 
f72-741, It hna recently been shown chat game chelators 
00 the carcinogenic metal nickel [59] also react with 
HZ@& to cause ‘OH-dependent damage to isolated 
DNA, Mixtures of eobnlt(IIj ions and &Or which arc 
thought to produce ‘OH [f!], again damaged DNA in 
a way characicristic of attack by ‘OH (Nzlekerdien, 
Rata, Haliiwcll, and Dizdaroglu, in preparation, 
A second cxphnation of the ability of’oxidativc stress 
to CQIISC BNA damage is that it triggers off a series of 
metabolic events within the cell 176,771 that lead to ac- 
tivation of nuclcasc enzymes, which cleave the DNA 
backbone. There has been muc.h debate recently concer- 
ning the suggestion that oxidative stress causes rises in 
intracellular free Ca’“, which might fragment DNA by 
activating Ca”*-dependent endonucicases [21,37,78] in 
a mechanism resembling that of apoptosis (‘programm- 
ed cell cieath’), An example of apoptosis is the killing of 
immature thymocytes by glucocorticoid hormones, 
which activate aself-destructive process that apparently 
involves Ca’*-dependent DNA fragmentation [79,80]. 
These two mechanisms (DNA damage by ‘OH or by 
activation of nucleases) arc not mutually exclusive, i.e. 
they could both take place. Indeed, there is evidence 
consistent with both of them. Their relative importance 
may depend on the cell type used and on how the ox- 
idative stress is imposed. For example, chelating agents 
that bind iron ions into chelates unable to generate “OH 
(such as desferrioxaminc [SlJ, desferrithiocin 1181, or 
phenanthroline [82]) can often protect ceils against 
DNA damage and other toxic effects of oxidative stress 
[30,31,34,38,73,83-$51, The effects of desfcrrioxamine 
are variable, since in general it does not cross cell mem- 
bran.es readily, although it appears to enter some cell 
types (such as hepatocytes) more readily than it enters 
others. Jonas et al. [29] showed that the toxicity of 
I-3202 to epithelial cells is greatly diminished at 4°C but 
it can be increased again by adding ascorbic acid: this 
effect is not seen if cells are pre-treated with desferriox- 
amine. Their observations are consistent with a 
mechanism of cell damage that depends on Hz02 and 
reduced iron ions: at high temperatures normal 
metabolism may provide a reductant (such as OF), 
tihereas at low temperatures ascorbate can replace it. 
Suggestive vidence that Fenton-type reactions can oc- 
cur within bacterial ceils has been presented [87-$93, 
although this is not necessarily relevant o mammalian 
systems. SHydroxyguanine (&OH-Oua) was increased 
in amount in’the DNA of P388 Dl cells after exposure 
Fig. 1, Myporlrcrcs to cxplnin DNA dnmngc resulting from exposing cells to oxihiw StrCs.s. 
to I-I202 [18]: d-OH-Gua can arise from attack of ‘OH 
upon guanine (see next section) but should not be pro- 
duced as a result of nuclease action. DNA isolated from 
P388 Dl cells after exposing them to Hz02 did not show 
a regular pattern of fragmentation, such as might be ex- 
pected from nuclease attack [ 181. Increases in g-OH- 
Gua have also been observed in DNA from other cells 
subjected to oxidative stress [90,91]. Thymine glycol, 
another product that can result ,from attack of ‘OH 
upon DNA (see next section) has been reported to be 
formed in the DNA of yeast cells after exposure to high 
concentrations of I-I202 [92] and in murine tumor cells 
after exposure to tumor necrosis factor [S 11. Treatment 
of murine hybridoma cells with Hz02 caused a pattern 
of chemical changes in the DNA bases that is 
characteristic of attack by ‘OH [93]. 
However, the evidence for metabolic changes pro- 
duced in cells by oxidative stress is also strong 
[21,39,96-991. Menadione and other quinones (which 
‘redox cycle’ within cells to give 02 and H202) appear 
to produce DNA strand breaks in hepatocytes by 
Ca2+-dependent activation of an endonuclease. DNA 
damage could be inhibited by preventing the rise in 
Ca2+ using Ca 2+-chelators [37,94]. Oxidative stress can 
also sometimes activate and/or cause changes in the 
subcellular location of PKC (protein kinase C) [95-993. 
Exposure of mouse epidermal JB6 cells to Hz02 ap- 
peared to cause a Cazc-dependent translocation of PKC 
to the piasma membrane [!X] whereas menadione ac- 
tivated PKC both in these cells and in rat hepatocytes 
[95,963 without producing translocation. Cantoni et al. 
[98] found that the Ca2’ -chelator quin 2 inhibited 
Fig, 2 trhow,a that both type% of experimental result 
may be nccommodnred by proposing that ohungca in the 
availability of calcium lona may depend upon, or give 
risa 10, changer in the availnbility oi+ iron or copper 
ions, Clearly, attempting co elucidate t;tvz mfchanism af 
DNA damage by thr use of free radical scavengers or 
metal ion chelators added to the outlsidc of ucllt ix 
unlikely 10 give unambiguous answers. Let 11s ee what 
can be learned from the techniques of molecular 
biology and analytical chemistry. 
3. REACTIVE OXYGEN SPECtES A$ MUTAGENS 
AND CARCINQGENS 
Oxidative stress, imposed by a variety of mechanisms 
(including increased 02 concentrations [98a]), has been 
convincingly shown to be mutagenic to bacteria 
[69,99-1031. For example, E. coli mutants bxking SOD 
activity show greatly-enhanced rates OF spontaneous 
mutation [99]. Similar mutagenic effects have been 
shown in a range of mammalian cell types (42,105-1071 
subjected to oxidative stress. Moraes et al. [108] studied 
the pattern of mutations obtained in a gene of a shuttle 
plasmid when simian cells transfectcd with this plasmid 
were exposed to HzOZ. Both single base changes and 
deletions were observed. The majority of base changes 
were at GC base pairs, the GC-+AT base transition be- 
Can mutationa lnduecd k314* t3xSdnrlvt: mw lasd ttl 
can&! IcMxing radiscion k well-known to bc both 
mutagenic and ~ar~~l~o~~nj~ (&I 10, I t I]. Since much crf 
the CC\! darnqc eauasd by xuch radiatian invslvcr ‘OH 
preduetien by kemelytic fisrian al rhcr tlxygen= 
hydroycn btlnda in waFerI then ‘GH can grabrbly bi: 
clnssifitld as a eompizrs carcinogen, Bascqair changes 
and Some frt?rnr&Ma are the eemrnoncot murririsns 
observed in cells exposed to ionizing radiation 
(I 10, it I], Chemical ckangcs In the: 5NA bases, aingic- 
and double-strand breaks and cnhnnecd cxprcs&on of 
certain prote-oncogcner [&I 12,113] have also been 
observed. WOwever, the prceise relationship between 
these differenr events tend rhc dcv~lopmttnt of cancer is 
uncertain. ‘i’hur, the chemical changes in DNA might 
themselves somehow lead to cancer [ LILE]. An 
unrepaired lesion in DNA mighr lx by-pasaccl in an 
error-prone fashion. Resynthesis of BNA after excision 
repair might conceivably introduce errors. 
Thcrt: are many steps between a healthy cell and a 
malignant tumor, Cancer biologists have often referred 
to at least three stages: initiation (an irreversible change 
in DNA), pramotion (probably involving changes in 
gene cxprcssion) and progression (further changes in 
DNA leading to the cvenrual production of a malignant 
tumor). Both Zimmerman and Ccructi [115] and Weitz- 
man et al. (1161 showed that a clone of C3H mouse 
fibroblasts exposed to activated human ncutrophils or 
to hypoxanthine plus xanthine oxidasc underwent 
malignant transformation* Nassi-Calo et al. 1117) 
showed that Hz02 also transformed these cells, an ac- 
tion prevented by the chelating agent o-phenanthrolinr. 
Fig. 2. A combined hypothesis. Rises in intracellular free iron or copper ion concentrations could be a consequence of rises in Ca”* (lB, 2B) 01 
vice versa (IA, 28). 
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Ahhougk mw r\trcnricw haa ken paid in ths 
lircraturr! to I hi(E acticsn of rewtivf mypen rpceicr yIx pro- 
mw33 of cawcinagencsia [ 115,120,121,123], their ablli- 
ty fo dam~tgc DNA and produce alrerarionu~ in gcnc ex= 
prexxion implies that they could bc involved in all srager 
af careinogeneais [124,127,129]. It bar been argued 
[42,130- 132] that canrinuoua: dama~? to DNA by free 
radical mechanisms ia B significant ERWJC of cftnccr in 
humans, nn abwvation rlw might explain rcaultn of 
the epicicmiologiral investigations, which show invlersc 
corrclarions in humans between plasma concentrations 
of certain an~ioxidants and rhe: incidence of cancer 
[ 131,133], However, several anrioxidnnfs can alter the 
metabolism of procarcinagcns, Favoring metabolic 
pathways rhar do nat result in formation of ultimate 
carcinogens [ 13 I ,134]. Menee a protective ffect OF an- 
tioxidants does 1101 r~ecesstrril,~ mean rhnt oxidtlrivc 
Stress leads fo the cancers in question. Of course, some 
carcinogens might act by imposing s?n oxidnrive stress 
on their target cells (Section 4), and reactive oxygen 
species have been claimed to be capable of converting 
some procarcinogcns into ultimate carcinogens 
[134,135]. In addition, it must be borne in mind thar a 
high plasma level of such antioxidants as ascorbic acid 
and vitamin E may simply be an index of a good diet, 
which protects against many diseases. 
DNA damage resulting from oxidative stress (or from 
any other mechanism) need not necessarily lead to 
cancer. Low lcvcls of damage may be efficiently 
repaired with a minimal risk of error, High levels of ox- 
idative stress may lead to cell death, so that initiated 
cells do not remain in the organism. Thus, an in- 
termediate level of damage is most likely to predispose 
to malignancy, which may explain the close association 
of chronic inflammation (involving phagocytic produc- 
tion of 02 and H202) with malignancy in such human 
diseases as ulcerative colitis, Crohn’s disease and reflux 
esophagitis (reviewed in [127]). Cerutti et al. [122] 
showed that one difference between a clone of mouse 
epiderrnal cells that was promotable by xanthine/xan- 
thine oxidase and a non-promotable clone was that the 
latter had lower levels of SOD and catalase and was 
more sensitive to killing by reactive oxygen species. 
Thus, increased antioxidant deferices, by protecting 
against cell death resulting from oxidative stress, might 
conceivably (and ironically) sometimes lead to increas- 
ed cancer [136,137]. 
Radiation chemists have carried we many rrudicP of 
the effcct~ of ‘OH, yencrnred by ionisingg radintion, 
upon DNA, Thix radictt! ia rota rrsctive that it can attack 
ail csmgoncntx of the DNA (reviewed in (4,138-1403). 
Thus, ‘OH abstracts hydrogen atoms Cam dwx- 
yribosc, giving su&ar radicals that can fragment in 
various ways. Reactions of deoxyribose-derived 
radicals can lead to lhe release of’ pwine nnd pyrimidine 
bnses from the DNA (producing abasic sites), and to 
strand breaks. Some of the altered sugars that rrmnin 
artnchcd to DNA can be xplir to give strand breaks by 
incubation with alkaline solutions; these are the so- 
called “alkali-labile sites [4,15,141]. Chemical changes 
to rhc purine and pyrimidinc bases have also been 
characrerized in detail (reviewed in [ 138-140)). Thus, 
‘OH can adcl on to guanine residues at C-4, C-5, and 
C-8 positions. For cxamplc, addition OF ‘OH to C-8 OF 
yuaninc produces a radical adduet rhat has scvcral 
possible fates. Ir can be reduced to Ghydroxy-7,8- 
dihydroguanine, osidized to &hydroxyyuaninc, or 
undergo ring opening followed by one-electron reduc- 
tion and protonation to give 2,G-diamino-4-hydroxy-S- 
formnmidopyrimidinc, usually abbreviated as FapyGua 
(Fig8 3), Similarly, ‘OH can add on to C4, CS, or C8 of 
adcninc residues: among other fates, the C-8 ‘OH 
adduct radical can be converted into 8-hydroxyadenine 
by oxidation, or undergo ring-opening followed by one- 
electron reduction to give 5-formarnido-4,6-diamino- 
pyrimidine (FapyAde). Fig. 4 shows the structures of 
sonic of these compounds. Pyrimidines in DNA are also 
attacked to give multiple products. Thus, thymine can 
form c/s and tram thymine glycols (5,6-dihydroxy-6- 
hydrothymines), %hydroxy+methylhydantoin, 5,G-di- 
hydrothymine and 5-hydroxymethyluracil. Cytosine 
can form several products, including cytosine glycol 
and 5,Gdihydroxycytosine (Fig. 4). 
When whole cells or isolated chrotnatin are exposed 
to ionizing radiation, cross-links can occur between 
DNA bases and amino acid residues in nuclear proteins 
[ 139,142-1481. Thus, thymine-tyrosine [ 1451, thymine- 
aliphatic amino acid [ 143- 1491, and cytosine-tyrosine 
[ 1463 links have been identified in isolated calf-thymus 
chromatin subjected to y-irradiation. Treatment of 
chromatin with Fe”‘-chelates and Hz02 also produces 
DNA-protein cross-links [153] and such !inkc, have been 
detected in cellular DNA after exposure of the cells to 
ozone [60]. 
Molecular biologists have examined the likely 
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physiological effects of these various lesions in DNA, situation with other reactive oxygen species is less clear- 
GHydrsxyguanine (and, by inference, &hydroxy- 
adenine) might lead to mutations by inducing mis- 
cut at prcscnt, Sinylac oxygen is able I0 produce limited 
reading of the base itself and of the adjacent bases 
strand breakage in isolated DNA [153,154], and its 
[llO,ll 1,151,152]. Thymine glycol might have some 
ability co modify the DNA bases is aIso limited (154a]. 
Thus, M. DizdnrogIu and H. Sits (personal com- 
mutagenic action and it can be lethal if not removed 
from the DNA before replication [ 1 10,ll l], Riny- 
fragmcnccd bases are thought co block DNA replication 
[I 10,ll I]. Abasic sites, which can result from direct at- 
tack of ‘OH, can also be mutagenic in vivo [I 10,l 111, 
It is clear chat ‘OH products multiple changes in 
DNA whereas 02” and Hz02 have no effect, but the 
munication) found small amounts of d-OH-Gua and 
FapyGua but no ocher significant base changes in DNA 
exposed to singlet 0~ gcneratcd by the thermal dccom- 
position of an endopcroxide. Exposure co illuminated 
Mechylene blue causes formation of &hydroxyguaninc 
[155] and of some strand breaks [I561 in DNA but the 
species responsible was not identified, except for the 
S-hydroxy-fi-mthyl- 
hydmtoin 
S-hydroryhydmtofn 5Aydroxyurocil 
S-hydtoxymotbyl- 
uracil 
S-hydroxycytoslne thymine elycol 5,6-dihydcoxy- 
uracil 
5,6-dihydroxy- 
cytosinc 
4,G-diamLm-5- 
Pormmidopyr@ddina 
8-hydroxyadcnino 2,6-dlamfno-4-hydroxy- 8-hydroxygunnine 
5-fomiamidopyrimidinc 
Fig. 4, Some of the end-products that result from attack of hydroxyl radicals upon the bases of’DNA. 
14 
Enbiefvation thar rcavenflarr at ‘OH did not protccc. 
Hawcver,dha excited state of the ph~to~en~iti~~n~ ,dya 
Raw&2 bengIl hWK iwlf been clrSmed ta clewve DNA [ 157) 
and, if ‘OH were $anerurcd by Mcthyirne blue bound to 
the DNA, then ‘01-I srcavenfi~r% would nar b+ experfcd 
10 pmteef. Elluminated ribcafhwin, which aenrratca 
rinatet CL WWJ regarted no1 to pradusc I-hydrtlxy- 
gurninc in DNA [l%t]. Thus, sin@et 8: certainly does 
nat induce the extenrive pattern af DNA base modifieta* 
tion produced by ‘a-s. 
Peroxidixing lipids hwe been reported to dxlmnp 
DNA flS9=163a] but peroxidizing lipids produce a 
rengc of reactive oxygen species including ‘OH, W&II, 
singlet oxyycn, peroxyl radicnls, and nlkoxyl radicals 
[69,164] i0xl the exact contributions of these species to 
the DNA damage observed need to be determined 
[165,166]. Lipid peroxides alno decompose to give tl 
huge range of producta [166-1683 ineluding carbonyl 
compounds, such na maiondia~dehyde and the un- 
saturated tlldchyde 4-hydroxy*2-lrnrrs nonenal [ 168] 
which has been shown to be mutagenic to mammalian 
cells [ 1691. If these aldehydcs arc generated in the vicini- 
ty of DNA, they mlry be able to combine with it to form 
distinctive products [165,169], Thus, malondialdchydc 
reacts with adcnine, eytosine, and guaninc [161,17011] 
and a guaninc-MDA adduet has been identified in 
human urine [ 1711, The product of reaction of hydroxy- 
nonenal with deoxyguanosinc has also been characceriz- 
ed [172]. 
Humans arc constantly exposed to background levels 
of ionizing radiation, which will generate some ‘OH in 
vivo. This radical may also arise by reaction of metal 
ions with H;rOz in vivo [5]. Thus, it is not surprising to 
find that repair systems have evolved to remove at least 
sotne of the lesions in DNA that can result from attack 
of ‘OH and other reactive oxygen species (reviewed in 
[ 173,174]). Single-strand breaks, ate usually quickly 
repaired; indeed, they are generated as intermediates in
the repair of other lesions (see below). 8-Hydtoxy- 
guanine is slowly removed from cellular DNA, but the 
repair mechanism is unknown [ 1731. Several lesions, in- 
cluding thymine glycol, are probably removed in 
human cells by action of a DNA glycosylase, which cuts 
the base-deoxyribose bond to give an abasic site. This 
site is recognized by an endonuclease activity (on the 
same enzyme), which nicks the strand at the abasic site. 
The damaged part of the strand is removed, followed by 
resynthesis of the DNA and re-joining of the strand by 
a DNA ligase enzyme. Glycosylases that recognize 
hydroxymethyluracil and ring-opened purines in DNA 
have also been described in mammalian cells 
[110,111,173,1743. 
Modified DNA bases and nucleosides (base-deoxy- 
ribose) have been detected in the urine of humans and 
other mammals. Thus, S-hydroxyadenine, 7-methyl-8 
-hydroxyguanine, thymine glycol, thymidine glycol, 
hydroxymethylutacil, 8-hydroxyguanine and B-hydao- 
xyd~o~~~~~~n~~~n~ huve bet?n detected in rn~rnrn~t~~n 
urine [f35,175-L781. The prcwxe erf these produan In 
urine ~~~~~e~r~ that axidativc damage to t hc fS‘NA bwec~ 
daes cxcuf In viva, and thwr repair nyatcnx ure wetiw to 
cleave modified b~tscir from DNA, ~“~OVI”CVC~, it ia pnnsi- 
tale! that xomc excreted bases ori&ate from the dicr or 
from the mernbralism af rho gut flora, and chat DNA 
relewd fram dead and dying cells within an erganlsm 
undergo+% rcyitl oxidaticr drmaae (since cell disruption 
can incrensc Free radical reaetions [69,72,164]). Hence, 
one must be eaurious in using the amounts af modified 
DNA brraca excreted ftam the body tls an index of thr 
extent of repair of oxidative DNA damage in hartlrlr~ 
eclls. 
5. MEASUREMENT OF BASE-DERW33 
PKXGJCTS AS A PROBE FOR THE 
MECHANISM AND EXTENT OF DNA 
DAMAGE 
The development of an I-WK tcchniquc, coupled 
with highly-sensitive clcetroehemical detection, for the 
measurement of &hydroxy-deoxyguanosine has led to a 
series of pioneering studies in which measurement aF 
this product has been used to gain information about 
free eadical damage to DNA in intact cells and whole 
organisms [91,114,179-1811. Antibody techniques for 
the measurement of such products as &hydroxyguanine 
and thymine glycol have also long been available (e.g. 
see [182-184)). Ames et al. [175-1771 have used the 
urinary excretion of products derived from guaninc and 
thyminc as an index of free radical damage to DNA in 
vivo, and have attempted to draw conclusions about 
changes in the rate of such damage as a function of age 
in mammals. The amount of 8-hydroxyguanine in the 
DNA from certain sub-populations of eat liver 
mitochondria was found to be considerably higher than 
that in nuclear DNA, leading to proposals about the 
role of mitochondria in aging and carcinogenesis 
[ 185,186]. Exposure of some cells to oxidative stress has 
been reported to lead to formation of Wydroxy- 
guanine in the DNA [22,90,91 , 14]. For example, treat- 
ment of Ehrlich ascites cells with the carcinogen 
4-nitroquinoline l-oxide led to an increased content of 
8-hydroxyguanine in DNA [187]. Intra-peritoneal injec- 
tion of ferric-nitrilotriacetic acid (which reacts with 
HZOZ to give ‘OH [9,10]) into rats produced a signifi- 
cant rise in the %hydroxyguanine content of kidney 
DNA [lSSJ. Carcinogenic peroxisome proliferators 
[189,190], acetoxime [191], 2-nitropropane [191] and, 
in one study, a choline-deficient diet [lgla], have all 
been reported to result in increased amounts of 
8-hydroxyguanine in DNA in vivo in mammals. 
These studies have certainly produced qualitative 
evidence for oxidative damage to DNA in vivo, 
although care must be used in interpreting the data 
[191b]. For ex\mple, nitroquinolines have been sug- 
Valum~ 261 I nwmkr I ,S FRFS 
yeated m form ~-hy~~rox~~~tanine in DNA by II 
mc?chanhn thut involves direct reacrion %rf the utrimetc 
eareinsgcn with RNA, rarhcr than by oxygen radical 
gencrarion [192], Qne must also bs exrremely cautious 
in awzmpring to use measuremcnl of any one product ax 
a quttntifnriva measure of DNA base damage by rcac- 
rive oxygen species. When ‘CM attacks DN4 bases, 
radicals are formed that can react in various ways 
depending on rhc candiriona used (Fig, 3 shows an cx- 
ample), Thus, acre& of ‘OH upon gunnine an lead IO 
fornwien of 8.hydroxyyunnine by oxidation of rhe C-8 
‘OH adduer radical, bur rhia radical can lead to orher 
products as well, depending on the reaction conditions. 
Thus, variable atnounts of &hydroxyguanine can resulr 
from attack of rhf same amount of ‘OH upon guaninc 
in DNA, and so changes in 84lydroxyfluanine levels do 
not necessarily mean changes in the amount of free 
radical attack upon DNA. To take some examples, 
iron-ion dependent systcri~ generating ‘OH led to 
substantial fortnarion of FnpyGua as well as 
84tydroxyguaninc in DNA (671, whereas systems con- 
taining copper ions and Hz01 greatly favored 
8-hydroxyguaninc production [6,7 I, 1931. When 
isolated, mammalian chromatin was irradiated in 
aqueous suspension, the relative atnounts of 8-hydro- 
xypurines and formamidopyrimidines generated 
depended upon the radical environment provided by the 
gases used to saturate the aqueous olution [194]. For 
example, the presence of oxygen favoured the forma- 
tion of %hydroxypurines [19$196]. Table I summarizes 
some of rhc results obtained, Products derived from 
pyrimidincs can similarly bc affected by changes in 
reaction conditions [195,196]. 
A complete characterization of damage to DNA by 
reactive oxygen species can be achicv,ed bg tl;; tcchni- 
que of gas chromatography/mass spectrometry (review- 
ed in [194a,197,198]), which may be applied to DNA 
itself or to DNA-protein complexes uch as chromatin. 
The DNA or chromatin are hydrolyzed and the pro- 
ducts .converted to volatile derivatives, which are 
separated by gas chromatography and identified by 
mass spectromctry. High sensitivity of detection can be 
achieved by operating the mass spectrometer in the 
selected ion monitoring (SIM) mode. In this mode, the 
mass spectrometer is set to monitor several ions derived 
by fragmentation of a particular product during the 
time at which this product is expected to emerge from 
the GC column. The GUMS-SIM technique is being 
used in the authors’ laboratories to examine the 
mechanism by which DNA is damaged in cells subjected 
to oxidative stress. Thus, if damage is due to ‘OH 
generation, then products characteristic of ‘OH attack 
should be detected (Fig. I), as has been observed in 
murine hybridoma cells treated with Hz02 [93] and in 
primate trachea1 epithelial cells exposed to ozone 
(Aruoma, Halliwell and Wu, in preparation). By con- 
trast, cleavage of the DNA backbone by the action of 
16 
0.55 0.57 
I,8 3.5 
0.8 0.95 
3.4 4.5 
nucleases hould leave the purines and pyrimidines 
unaltered (Figs. 1 and 2). For studies on DNA 
modification, extraction of chromatin from cells for 
analysis is preferable to extraction of DNA, since it 
minimizes the loss of extensively-fragmented DNA, and 
of DNA that has becotne covalently cross-linked fo pro- 
tein. 
GUMS-SIM has been used to characterize the 
damage done to DNA by various reactive oxygen 
species. Hydroxyl radical appears to produce a 
uniquely-extensive pattern of base modifications 
(multiple products from all four bases), cind this pattern 
seems to be a ‘fingerprint’ for ‘OH, i.e., it can be used 
to identify ‘OH as a damaging species [6,9,68, 
71,139,143,146,152,193,194,196,198,201]. For exam- 
ple, measurement of damage to the DNA bases by 
GUMS-SIM has been used to show that the strand 
cleavage produced in isolated DNA by treatment with a 
copper-ion phenanthroline &elate probably involves 
‘OH [ 1931, whereas DNA cleavage by a bleomycin-iron 
ion complex is not mediated by ‘OH [ 1991. GUMS has 
also been used to identify &OH&a, FApyAde, 
8-OHAde and FApyGua in neoplastic tissues [200], to 
show that the damage done to the bases in isolated 
DNA by activated human neutrophils is most likely due 
to ‘OH generated by reactions involving metal ions in 
the reaction mixture [2Ol], to measure adducts of car- 
cinogens with proteins in vivo in attempts to assess car- 
cinogen exposure [202] and to characterize the changes 
produced in plasmid DNA by treating it with potassium 
permanganate [203]. The authors believe that such 
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